Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line Fumiyuki YamasakiSeiji HamaKaoru Kurisu Original Article 20 March 2003 Pages: 271 - 283
Tamoxifen induces apoptosis in Fas+ tumor cells by upregulating the expression of Fas ligand Nisha NagarkattiBarbara A. Davis Original Article 27 March 2003 Pages: 284 - 290
The schedule-dependent effects of etoposide in leukaemic cell lines: a function of concentration and duration Wai M. LiuSimon P. Joel Original Article 05 March 2003 Pages: 291 - 296
Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer Randall P. RagoAlbert Einstein Jr.William S. Dalton Original Article 13 March 2003 Pages: 297 - 305
The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice Mohamed A. I. Abou El HassanMarc A. KeddeWim J. F. van der Vijgh Original Article 22 March 2003 Pages: 306 - 310
High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL) T. SkärbyP. JönssonP. Höglund Original Article 28 March 2003 Pages: 311 - 320
Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology Kristan A. KeyesLarry MannBeverly A. Teicher Original Article 18 March 2003 Pages: 321 - 327
Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer Stacy S. ShordStephanie R. FaucetteCeleste Lindley Original Article 13 March 2003 Pages: 328 - 336
Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma Philip C. MackDavid R. GandaraPaul H. Gumerlock Original Article 25 March 2003 Pages: 337 - 348
Oxygen-15 positron-emission tomography for predicting selective delivery of a chemotherapeutic agent to hepatic cancers during angiotensin II-induced hypertension Toshimori KohHiroki TaniguchiHisakazu Yamagishi Original Article 05 March 2003 Pages: 349 - 358
Bleomycin-mediated electrochemotherapy in mouse NR-S1 carcinoma Akira Kitamura Short Communication 21 March 2003 Pages: 359 - 362
